REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2-Reference-Cited by-同舟云学术

REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

Published:1999-01 Issue:2 Volume:67 Page:276-284
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Kahan Barry D.,Rajagopalan P. R.,Hall Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference31 articles.

1. Interleukin-2: Inception, Impact, and Implications

2. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

3. Interleukin-2 Receptor β Chain Gene: Generation of Three Receptor Forms by Cloned Human α and β Chain cDNA's

4. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.

Cited by 437 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap;Advanced Drug Delivery Reviews;2024-10

2. Hospitalizations after Renal Transplantation in Children: Risk Factors, Causes, and Outcomes;Nephron;2023-11-02

3. Point-of-care non-invasive enzyme-cleavable nanosensors for acute transplant rejection detection;Biosensors and Bioelectronics;2022-11

4. The impact of different induction immunosuppression protocols on patient survival, graft survival and acute graft rejection after kidney transplantation;Bratislava Medical Journal;2022-07-23

5. Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation;Transplant International;2022-05-20